A new series of two-armed quinazolin-2,4-diones incorporating N- heterocyclic moieties such as β-lactam, piperidine and/or morpholine, 2-thioxo imidazolidin-4-one and 2-iminothiazolidin-4-one 2-7 were designed and synthesized as attractive anti-fungal scaffolds.The structural elucidation of newly compounds was performed by means of FT-IR, 1H NMR, 13C NMR and MS techniques.Subsequently, the newly synthesized compounds were screened for their antifungal activity against Candida albicans via measuring the inhibition zone diameter around the fungal growth.The results obtained revealed varied response activity toward the tested fungal pathogen.Three most potent compounds 1, 3, and 4 exhibited noted inhibitory effects.Since, there was found superiority of the compound 1 in terms of inhibition zone diameter (mm) about the standard drug (i.e. Amphotericin B).Addnl., the MIC value was assessed for the potent compounds using different concentrations (5-400 μg/mL).A significant MIC value (20 μg/mL) was recorded for compound 1.Moreover, the mol. docking simulation was performed against sterol 14-alpha demethylase.In particular, compound 1 exhibited the best binding profile among the synthesized compounds (- 13.6 kcal/mol), followed by compounds 3 (-12.7 kcal/mol) and 4 (-11.9 kcal/mol).The structure activity relationship revealed the importance of electron withdrawing groups (chlorine atoms) on biol. activity of compoundsFurther, the eight compounds exhibited good ADMET profile and satisfied the Lipinski rule of drug likeness.